A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report contains market size and forecasts of Vaccines in global, including the following market information:
Global Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vaccines Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Vaccines companies in 2021 (%)
The global Vaccines market was valued at 46590 million in 2021 and is projected to reach US$ 67140 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vaccines include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Vaccines Market Segment Percentages, by Type, 2021 (%)
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Global Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Vaccines Market Segment Percentages, by Application, 2021 (%)
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Global Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vaccines revenues share in global market, 2021 (%)
Key companies Vaccines sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan